tiprankstipranks
Advertisement
Advertisement
Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)
PremiumThe FlySionna Therapeutics reports Q1 EPS (60c), consensus (50c)
9d ago
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
16d ago
Sionna Therapeutics initiated with an Outperform at Wedbush
Premium
The Fly
Sionna Therapeutics initiated with an Outperform at Wedbush
17d ago
Sionna Therapeutics files automatic mixed securities shelf
PremiumThe FlySionna Therapeutics files automatic mixed securities shelf
3M ago
Sionna Therapeutics files automatic mixed securities shelf
Premium
The Fly
Sionna Therapeutics files automatic mixed securities shelf
3M ago
Sionna Therapeutics files automatic mixed securities shelf
Premium
The Fly
Sionna Therapeutics files automatic mixed securities shelf
3M ago
Sionna Therapeutics price target raised to $58 from $50 at BTIG
PremiumThe FlySionna Therapeutics price target raised to $58 from $50 at BTIG
4M ago
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
Premium
The Fly
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
5M ago
Sionna Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Sionna Therapeutics initiated with an Outperform at LifeSci Capital
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100